Antimicrobial management in nosocomial peritonitis: microbiota, drug and time.
Rev Esp Quimioter
; 30 Suppl 1: 34-38, 2017 Sep.
Article
en En
| MEDLINE
| ID: mdl-28882013
ABSTRACT
Complicated intra-abdominal infection requires surgical treatment and broad-spectrum empiric antibiotic treatment used early. The rapid spread of multidrug-resistant bacteria has become a serious threat, especially in critical care units. The excessive use of carbapenems has led to carbapenemase-producing Enterobacteriaceae, leaving tigecycline and colistin as therapeutical options. The new antimicrobials, ceftazidime-avibactam and ceftolozane-tazobactam open new horizons in the treatment of multi-drug resistant Enterobacteriaceae. Candida peritonitis causes a high mortality in the critical patient. Diagnosis and early treatment are associated with a better prognosis, the administration of an echinocandin being of choice in these patients.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Peritonitis
/
Infección Hospitalaria
/
Microbiota
/
Antiinfecciosos
/
Antibacterianos
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Rev Esp Quimioter
Asunto de la revista:
TERAPIA POR MEDICAMENTOS
Año:
2017
Tipo del documento:
Article